GLY-PRO-GLY-GLY(13054-03-0)
- Name: GLY-PRO-GLY-GLY
- Synonyms:Antiarrhythmicpeptide (ox atrium), 3-de(trans-4-hydroxy-L-proline)-5-de-L-alanine-; Glycine,N-[N-(1-glycyl-L-prolyl)glycyl]- (7CI,8CI); 116: PN: US20040172667 SEQID: 26unclaimed protein; 13: PN: US20050065328 SEQID: 22 unclaimed protein; 151: PN:US20050037430 SEQID: 151 unclaimed sequence; 165: PN: WO2008137681 SEQID: 264claimed protein; 169: PN: US20040001851 SEQID: 99 unclaimed protein; 22: PN:US20050031582 SEQID: 22 unclaimed sequence; 22: PN: US20050054564 SEQID: 22unclaimed sequence; 23: PN: WO2007149355 SEQID: 27 unclaimed sequence; 26: PN:WO2004067707 SEQID: 26 unclaimed protein; 26: PN: WO2008143910 SEQID: 17 unclaimedsequence; 27: PN: US20080199398 SEQID: 27 claimed protein; 2: PN: WO2004067706SEQID: 81 unclaimed protein; 3: PN: WO2004090096 PAGE: 21 unclaimed sequence;41: PN: WO2005062881 SEQID: 32 unclaimed sequence; 5: PN: US7527966 SEQID: 5unclaimed protein; 94: PN: US20040235011 SEQID: 81 unclaimed sequence; 96: PN:WO2004067743 SEQID: 81 unclaimed protein; Glycyl-L-prolylglycylglycine; NSC89624
- Molecular Formula:C11H18 N4 O5
- Molecular Weight:286.288
- CAS Registry Number:13054-03-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 22750-65-8/ACETAMIDENNFLUOREN25YLENEBIS
- 50657-33-5/N2'-Deacetyl-15-hydroxy-N2'-(2-methyl-1-oxopropyl)maytansine
- 133627-10-8/BI-RG-587 analog
- 68919-53-9/Fatty acids, soya, Me esters
- 91480-92-1/1-[4-amino-5-(3,4-dichlorophenyl)-2-methyl-1H-pyrrol-3-yl]ethanone
- 5832-55-3/2-METHYLENE-3-QUINUCLIDINONE HYDROCHLORIDE HYDRATE
- 78940-62-2/2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile
- 89367-58-8/2,2,5,5-tetramethylpyrroline-1-oxyl-3-carboxy ethylhydrazine
- 99194-04-4/
- 130827-01-9/1,4-Ethenoindeno[4,5-d][1,2]dioxepin-7a(1H)-carboxylicacid, 4,5,5a,6,7,8,9,10,10a,10b-decahydro-5a,11-dimethyl-8-(1-methylethyl)-,(1R,4R,5aS,7aS,8R,10aS,10bS)-
- 68133-52-8/1,4-Butanediol, dimethyl terephthalate, isophthalic acid, sebacic acid, hexahydrophthalic anhydride polymer
- 104802-77-9/6-amino-7-methyl-1,7-dihydro-2H-purine-2-thione
- 124569-01-3/Phosphoric acid,diammonium salt, mixt. with ammonium bromide ((NH4)Br), ammonium dihydrogenphosphate and sodium chloride (NaCl) (9CI)
- 67674-39-9/4-(Isobutyl)-1-cyclohexene-1-acetonitrile
- 74131-09-2/5-(2-bromovinyl)-2'-deoxycytidine
- 1763-23-1/HEPTADECAFLUOROOCTANESULFONIC ACID
- 59886-44-1/2,5-bis(aziridin-1-yl)-3,6-di(pyrrolidin-1-yl)cyclohexa-2,5-diene-1,4-dione
- 7251-11-8/(15R)-20-chloro-12,15-dihydroxy-15,20-dihydrosenecionan-11,16-dione hydrochloride (1:1)
- 13054-03-0/GLY-PRO-GLY-GLY
- 10282-51-6/N-(5-chloro-2-methylphenyl)benzamide
- 257-29-4/Cyclohepta[b][1,4]diazepine
- 7732-92-5/4,5α-Epoxy-6α-methoxy-17-methylmorphinan-3-ol
- 75360-21-3/5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid,7-[[(2Z)-(2-amino-4- thiazolyl)(methoxyimino)acetyl]amino]-8-oxo- 3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]- methyl]-,(6R,7R)-
- 167568-92-5/3,10,17-Trioxatricyclo[11.3.1.02,4]heptadec-7-en-11-one,9-[(1S)-1,2-dimethyl-2-propenyl]-13-hydroxy-14-methyl-6,15-bis(methylene)-,(1R,2S,4R,7E,9R,13R,14S)- (9CI)
- 14591-03-8/potassium 9-oxo-9H-fluorene-2-sulfonate
- 745-34-6/5-Butyl-1,3-diphenylbarbituric acid
- 3074-77-9/3-Ethyl-4-methylhexane
- 124379-59-5/1-[3-deoxy-3-(1H-pyrazol-1-yl)-beta-D-arabinofuranosyl]-5-methylpyrimidine-2,4(1H,3H)-dione
- 56175-91-8/4-{[2-(trifluoromethyl)phenyl]amino}pyridine-3-sulfonamide
- 63460-09-3/3-bromo-2,5-dinitroaniline